Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease - a Retrospective Multi-center Data Analysis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07102823

Acronym

COPD-PH

Enrollment

1000

Registered

2025-08-05

Start date

2025-09-01

Completion date

2027-12-31

Last updated

2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hypertension

Keywords

pulmonary hypertension, chronic obstructive pulmonary disease, right heart catheterization

Brief summary

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* clinical diagnosis of COPD * right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output) * age \>= 18 years

Exclusion criteria

* pediatric patients * no COPD or no RHC

Design outcomes

Primary

Measure	Time frame	Description
Severe Pulmonary Hypertension (PH)	at inclusion	pulmonary vascular resistance \> 5 WU (Wood Units)
all-cause mortality	Until 2026	all-cause mortality

Countries

Austria, Switzerland, United Kingdom

Outcome results